proteinprotein
interact
within
protein
network
shape
human
interactom
often
promot
special
protein
interact
modul
postsynapt
discslarg
zona
occluden
pdz
domain
pdz
domain
play
role
sever
cellular
function
cellcel
commun
polar
regul
protein
transport
protein
metabol
pdz
domain
protein
also
crucial
format
stabil
protein
complex
establish
import
bridg
extracellular
stimuli
detect
transmembran
receptor
intracellular
respons
pdz
domain
suggest
promis
drug
target
sever
diseas
rang
neurolog
oncolog
disord
viral
infect
review
author
describ
structur
genet
aspect
pdzcontain
protein
discuss
current
statu
develop
smallmolecul
peptid
modul
pdz
domain
overview
potenti
new
therapeut
intervent
pdzmediat
protein
network
also
provid
postgenom
era
becom
clear
number
gene
determin
biolog
function
complex
rather
intricaci
interact
protein
also
known
interactom
uniqu
interact
describ
human
sever
wwwadvancedsciencenewscom
wwwadvtherapcom
figur
canon
fold
pdz
domain
show
six
two
ligand
blue
insert
bind
pocket
canon
insert
hydrogen
bond
network
orang
dash
line
backbon
pdz
domain
backbon
peptid
b
noncanon
fold
two
pdz
domain
overal
globular
fold
remain
intact
ntermin
ctermin
place
instead
respect
red
dot
sphere
c
domain
fold
two
nonfunct
monomer
domain
two
domain
swap
order
complet
fold
function
dimer
pdz
tandem
canon
insert
mode
often
reli
interact
ligand
p
carboxyl
acid
amin
backbon
pdz
domain
insert
p
side
chain
hydrophob
pocket
furthermor
interact
often
strengthen
either
insert
interact
p
hydrophob
caviti
class
ii
ligand
conserv
charg
residu
class
ligand
often
e
pdz
domain
ligand
also
bind
use
intern
motif
usual
still
reli
insert
hydrophob
residu
bind
pocket
either
hydrophob
hydrogen
bond
interact
coordin
p
interact
also
reli
p
p
residu
neg
charg
gluasp
use
carboxyl
acid
substitut
ctermin
f
bind
mode
mani
way
resembl
e
bend
allow
ligand
cover
twice
surfac
area
stabil
format
insert
part
intermolecular
hydrogen
bond
overal
stabil
interact
tic
scaffold
protein
case
sapap
dock
second
hydrophob
pocket
form
ntermin
extens
loop
pdz
domain
yet
distinct
bind
mode
variat
canon
interact
p
buri
deeper
bind
groov
pdz
domain
occupi
correspond
p
posit
figur
addit
case
gli
p
induc
conform
flexibl
within
ligand
backbon
wherebi
p
amino
acid
shift
occupi
p
posit
anoth
exampl
cy
p
enabl
ligand
bind
two
distinct
posit
canon
upward
shift
insert
p
amino
acid
convent
hydrophob
bind
pocket
allow
p
make
salt
bridg
ly
posit
ntermin
stabil
bind
pdz
domain
also
bind
phosphopeptid
suggest
involv
phosphoregul
pdz
domain
interact
thu
ad
plastic
pdz
domainmedi
interact
addit
carboxylatedepend
bind
pdz
domain
recent
demonstr
pdz
domain
also
bind
intern
peptid
motif
phospholipid
interact
neuron
nitric
oxid
synthetas
nno
structur
syntrophin
pdz
domain
exampl
bind
intern
peptid
motif
entir
peptid
figur
compris
two
connect
sharp
requir
wwwadvancedsciencenewscom
wwwadvtherapcom
bind
therebi
occupi
twice
surfac
area
peptid
bind
pdz
domain
canon
carboxylatedepend
fashion
carboxyl
bind
loop
pdz
domain
play
essenti
role
coordin
backbon
carbonyl
phe
p
phe
analog
role
hydrophob
p
residu
canon
ctermin
peptid
ligand
occupi
hydrophob
pocket
case
phospholipid
pdz
domain
gener
lack
welldefin
bind
pocket
pdzphospholipid
interact
map
differ
structur
region
distinct
case
review
detail
previous
gener
neg
charg
phospholipid
head
group
stabil
posit
charg
cluster
phospholipid
bind
site
syntenin
protein
interact
c
kinas
pdzphospholipid
interact
shown
crucial
cluster
membran
receptor
cell
membran
redoxdepend
manner
addit
multifacet
behavior
pdz
domain
sever
shown
form
dimer
structur
homoor
heterodimer
instanc
second
pdz
domain
shown
homodimer
via
domain
swap
one
domain
swap
second
domain
domain
domain
complet
correct
fold
shape
ligand
bind
pocket
see
figur
cy
residu
loop
shown
facilit
redoxdepend
homodimer
singl
pdz
domain
believ
contribut
ligand
bind
capabl
past
decad
becom
evid
structur
function
properti
pdz
domain
affect
extens
beyond
convent
pdz
domain
structur
core
form
function
independ
unit
supramodul
extens
small
secondari
structur
element
add
pdz
domain
structur
core
exemplifi
third
pdz
domain
contain
addit
ctermin
influenc
ligand
bind
alloster
mechan
case
pdz
supramodul
form
neighbor
domain
either
homotyp
heterotyp
fashion
figur
support
inform
homotyp
tandem
two
domain
restrict
short
linker
posit
two
domain
antiparallel
fashion
protein
whirlin
longer
flexibl
linker
allow
greater
flexibl
tandem
pdz
domain
gener
homotyp
pdz
tandem
domain
facilit
either
bind
multipl
copi
singl
protein
multipl
subunit
protein
complex
figur
support
inform
interact
altern
pdz
tandem
domain
bind
differ
particip
protein
complex
one
subunit
one
nno
bind
one
tandem
howev
tandem
supramodul
function
one
pdz
domain
exclus
stabil
pdz
domain
case
tandem
glutam
receptorinteract
protein
grip
compris
seven
pdz
domain
fold
bind
one
pdz
domain
requir
presenc
pdz
domain
tandem
exclus
act
chaperon
contribut
receptor
bind
heterotyp
supramodul
pdz
domain
combin
modular
protein
domain
includ
guanyl
kinas
gk
domain
seen
membraneassoci
guanyl
kinas
maguk
superfamili
protein
figur
support
inform
exampl
demonstr
three
domain
fold
heterotyp
supramodul
increas
peptid
affin
significantli
compar
isol
domain
similarli
interact
maguk
subfamili
member
protein
crumb
homolog
crb
affin
increas
upon
bind
entir
supramodul
compar
isol
pdz
domain
case
synapt
ra
gtpaseactiv
protein
syngap
bind
psd
protein
structur
studi
show
linker
region
fold
upon
bind
syngap
stabil
overal
complex
increas
affin
eightfold
fourfold
respect
henc
supramodular
structur
pdz
domain
often
finetun
specif
select
consid
develop
pdz
domain
direct
inhibitor
pdz
domaincontain
protein
highli
involv
distinct
biolog
process
cell
cycl
signal
transduct
metabol
accord
avail
annot
human
pdzcontain
protein
reactom
databas
manual
curat
experiment
proven
peerreview
pathway
tabl
pdz
domain
protein
primarili
involv
one
pathway
group
specif
signal
transduct
cell
cycl
involv
plethora
differ
process
tabl
support
inform
exampl
proteasom
nonatpas
regulatori
subunit
occur
sever
protein
degrad
process
throughout
human
interactom
anoth
exampl
pdz
domaincontain
protein
particip
transport
small
molecul
within
vitamin
metabol
microbi
hostpathogen
interact
pathway
pathway
includ
sever
differ
pdzcontain
protein
tabl
tabl
support
inform
annot
protein
particip
sever
pathway
recapitul
common
function
pdz
domain
protein
scaffold
protein
string
interact
databas
pdzcontain
protein
list
experiment
valid
predict
interact
form
dens
interact
network
map
use
basic
string
algorithm
figur
though
map
interact
mediat
pdz
domain
protein
major
mediat
either
canon
noncanon
pdz
bind
mode
pdzcontain
protein
network
contain
one
pdz
domain
andor
ctermin
pdz
bind
motif
sever
share
ligand
interact
figur
rich
cross
interact
combin
pathway
data
adv
highnetwork
densiti
observ
altogeth
underlin
fundament
import
pdz
domain
interact
sinc
pdz
domaincontain
protein
involv
numer
signal
pathway
surpris
also
associ
rang
diseas
disord
besid
well
character
involv
pdz
domain
protein
neurodegen
mental
disord
also
involv
diseas
hear
loss
vision
disord
metabol
disord
kidney
heart
condit
tabl
support
inform
provid
overview
insight
role
diseasecaus
mutat
protein
contain
pdz
domain
extens
search
conduct
use
publicli
avail
genediseas
associ
gene
encod
human
pdzcontain
protein
tabl
support
inform
protein
subsequ
examin
diseasecaus
mutat
locat
pdz
domain
outlin
tabl
support
inform
amino
acid
variat
within
pdz
domain
known
associ
diseas
human
pdz
domain
peripher
plasma
membran
protein
calciumcalmodulindepend
serin
protein
kinas
cask
frameshift
stop
codon
mutat
substitut
demonstr
present
case
mental
retard
protein
mark
circl
color
accord
biolog
process
go
term
enrich
protein
contain
canon
pdz
bind
motif
cterminu
mark
black
dot
line
protein
repres
experiment
evid
proteinprotein
interactionth
thicker
line
higher
confid
evid
figur
made
use
string
databas
inform
analysi
visual
tool
mutat
smithmageni
syndromelik
development
disord
tabl
support
inform
adjac
assess
protein
sequenc
figur
close
proxim
protein
structur
moreov
appear
interact
crystal
experi
thu
specul
mutat
part
pdz
domain
could
disrupt
caus
interact
drive
diseas
mutat
first
pdz
domain
glutam
receptorinteract
protein
locat
two
residu
downstream
residu
diseasecaus
mutat
cask
accord
sequenc
align
figur
contribut
abnorm
brain
morpholog
addit
mutat
ntermin
region
domain
caus
cryptophthalmo
syndrom
skin
anomali
caus
partial
complet
fusion
eyelid
mutat
ubiquitinprotein
ligas
shown
correl
schizophrenia
wwwadvancedsciencenewscom
wwwadvtherapcom
mutat
locat
loop
known
involv
interact
canon
ligand
pdz
bind
motif
muscl
skelet
receptor
tyrosineprotein
kinas
musk
number
differ
mutat
two
protein
harmonin
whirlin
whrn
associ
hear
vision
loss
disord
includ
usher
syndrom
tabl
support
inform
mutat
locat
close
proxim
canon
bind
site
pdz
domain
like
directli
interf
function
pdz
domain
numer
diseasecaus
mutat
pdz
domain
locat
away
canon
bind
site
figur
may
indirect
effect
pdz
domain
function
alloster
effect
perturb
structur
modul
multiprotein
complex
format
combin
exampl
mutat
pdz
domain
caus
metabol
diseas
aciduria
mutat
tight
junction
protein
caus
hypercholanemia
exampl
pdz
domain
lim
domain
bind
protein
ldb
pdz
lim
domain
protein
relat
heart
muscl
diseas
cardiomyopathi
moreov
mutat
na
h
exchang
regulatori
cofactor
relat
kidney
stone
thu
well
diseaseassoci
mutat
case
figur
highlight
role
pdz
domain
sever
diseas
genomewid
associ
studi
elucid
diseas
relev
mutat
gene
encod
protein
contain
pdz
domain
howev
correct
mutat
use
gene
therapi
current
limit
yet
avail
pdz
domain
protein
therefor
modif
diseas
pathway
gener
achiev
small
molecul
peptid
modul
ppi
select
interfer
downstream
signal
cascad
target
ppi
consid
challeng
mainli
due
extens
bind
interfac
view
chang
sinc
sever
ppi
modul
bind
high
affin
approv
medicin
major
ppi
modul
interact
directli
surfac
one
protein
target
act
competit
antagonist
prevent
format
heterodim
product
strategi
success
use
design
highaffin
pdz
inhibitor
toward
neurolog
also
cancer
target
one
ligand
reach
latestag
clinic
trial
anoth
approach
base
alloster
modul
ppi
bind
protein
region
within
surfac
bind
site
two
protein
partner
even
though
alloster
modul
use
protein
domain
studi
target
pdz
domain
therapeut
applic
scarc
final
two
strategi
ppi
modul
recent
describ
yet
appli
toward
pdz
domain
protein
first
instead
inhibit
ppi
use
competit
antagonist
interact
stabil
upon
ligand
bind
second
signal
pathway
modifi
direct
reduct
one
interact
protein
use
proteolysi
target
chimera
protac
next
section
applic
pdz
target
treatment
neurolog
diseas
cancer
treatment
discuss
focus
develop
orthoster
inhibitor
larg
number
pdz
domaincontain
protein
associ
neurolog
disord
among
other
regul
synapt
membran
exocytosi
protein
partit
defect
homolog
b
peripher
plasma
membran
protein
cask
disk
larg
homolog
associ
neurodevelopment
disord
central
nervou
system
develop
disord
differ
manifest
protein
like
mani
pdz
domain
protein
particip
pathway
crucial
brain
function
development
process
synapt
regul
figur
tabl
support
inform
addit
pdz
domaincontain
protein
particip
nervou
system
src
homolog
domain
multipl
ankyrin
repeat
domain
protein
link
autism
spectrum
disord
like
alter
synapt
pathway
synapt
pdzcontain
protein
involv
neurolog
disord
includ
neurodegen
diseas
membraneassoci
guanyl
kinas
ww
pdzcontain
protein
maguk
subfamili
member
particip
regul
signal
event
associ
alzheim
diseas
ad
tabl
support
inform
hallmark
ad
abnorm
aggreg
protein
synaps
sever
synapt
pdzcontain
protein
might
involv
patholog
event
pdzcontain
protein
connector
enhanc
kinas
suppressor
serin
proteas
maguk
subfamili
member
nitric
oxid
synthas
partit
defect
homolog
link
parkinson
diseas
sever
pdzcontain
protein
involv
psychiatr
disord
least
eight
differ
pdzcontain
protein
associ
depress
associ
schizophrenia
tabl
support
inform
pdz
domain
also
associ
hear
vision
disord
tabl
support
inform
pdz
domaincontain
protein
tight
junction
protein
harmonin
whirlin
whrn
associ
hear
loss
two
whrn
togeth
two
pdzcontain
protein
also
associ
retin
pigmentosa
genet
disord
affect
sight
evid
suggest
whrn
involv
usher
syndrom
diseas
affect
hear
vision
exampl
well
annot
proteindiseas
relationship
howev
addit
pdzcontain
protein
like
implic
similar
pathogen
process
wwwadvancedsciencenewscom
wwwadvtherapcom
figur
select
pdzcontain
protein
involv
neurolog
diseas
protein
mark
circl
color
accord
biolog
process
go
term
enrich
line
protein
repres
experiment
evid
proteinprotein
interactionth
thicker
line
higher
confid
evid
map
done
use
string
databas
master
scaffold
protein
one
first
protein
pdz
domain
identifi
togeth
protein
syngap
repres
core
synapt
scaffold
highli
express
adult
mous
brain
highest
express
level
hippocampu
cortex
olfactori
bulb
neuron
highli
enrich
synapt
region
especi
postsynapt
densiti
psd
encod
gene
found
chromosom
span
approxim
kb
associ
neurolog
disord
previous
discuss
search
databas
mention
shown
associ
sever
neurolog
disord
includ
schizophrenia
major
depress
disord
mdd
autism
spectrum
disord
asd
figur
tabl
support
inform
variat
associ
schizophrenia
recent
shown
epigenet
edit
could
rescu
memori
deficit
mous
model
alzheim
diseas
also
found
higher
express
level
later
amygdala
patient
mdd
compar
healthi
individu
recent
studi
show
differ
epigenet
factor
prefront
cortex
hippocampu
addit
sever
variant
found
cancer
patient
total
differ
mutat
found
pdz
domain
tabl
support
inform
three
isoform
character
result
altern
splice
ntermin
region
preced
pdz
domain
uniprot
mous
human
canon
isoform
aa
protein
aa
ntermin
region
isoform
contain
aa
includ
aa
ntermin
region
isoform
compos
aa
aa
nterminu
uniprot
contain
palmitoyl
site
contain
ntermin
domain
figur
sever
posttransl
modif
ptm
found
regul
structur
function
among
palmitoyl
previous
describ
well
sever
phosphoryl
found
influenc
function
local
mobil
acid
receptor
ampar
nmethyldaspart
receptor
nmdar
togeth
synapseassoci
protein
postsynapt
densiti
protein
core
member
maguk
superfamili
figur
support
inform
common
domain
topolog
three
pdz
domain
domain
gk
domain
describ
section
primari
role
stabil
anchor
membran
protein
complex
synapt
membran
case
ampar
nmdar
direct
indirect
associ
cluster
receptor
larger
signal
complex
figur
interact
nmdar
primarili
mediat
direct
interact
cterminu
subunit
figur
furthermor
complex
stabil
interact
nmdar
auxiliari
subunit
neuropilin
tolloidlik
protein
similarli
interact
ampar
complex
bind
ampar
auxiliari
subunit
voltagedepend
calcium
channel
subunit
also
known
transmembran
ampa
receptor
regulatori
protein
tarp
stargazin
bind
predominantli
figur
furthermor
hold
key
role
nnosmedi
product
follow
abnorm
synapt
ca
influx
result
ischem
stroke
nno
bind
primarili
noncanon
insert
motif
bind
pocket
figur
interact
nno
ensur
nno
nmdar
close
proxim
ca
influx
normal
condit
lead
gener
requir
signal
howev
excitotox
condit
massiv
calcium
influx
nmdar
activ
nno
lead
gener
toxic
level
therefor
keen
interest
disrupt
ternari
complex
repres
potenti
novel
mode
action
treatment
ischem
stroke
current
mani
inhibitor
design
target
pdz
domain
multipl
promis
lead
candid
number
smallmolecul
inhibitor
figur
tabl
target
interact
identifi
screen
compound
librari
identifi
methyl
inhibitor
interact
ic
examin
vivo
nocicept
effect
mice
intrathec
administr
show
signific
pain
reduc
effect
pmol
presenc
nmda
effect
absenc
nmda
furthermor
test
chronic
constrict
injuri
cci
model
neuropath
pain
display
allevi
effect
pain
percept
similar
effect
seen
administ
variant
nno
fuse
cell
penetr
peptid
cpp
tat
structureact
relationship
sar
studi
lead
discoveri
shown
inhibitor
interact
follow
glutamateglycin
treatment
ic
valu
nm
cultur
cortic
neuron
shown
amelior
cerebr
ischem
brain
damag
mice
administ
middl
cerebr
arteri
occlus
mcao
later
studi
shown
promis
effect
result
forc
swim
test
regen
repair
follow
transient
maco
tmcao
induc
stroke
recent
studi
rais
doubt
rapidonset
antidepress
effect
mice
due
rel
poor
cellular
uptak
compound
reformul
encapsul
liposom
conjug
polyethylen
glycol
peg
target
transferrin
receptor
enhanc
uptak
formul
increas
cellular
uptak
compar
show
decreas
infarct
volum
follow
mcao
iv
inject
studi
shown
dual
conjug
stroke
home
peptid
shp
liposom
increas
accumul
liposom
affect
brain
area
follow
mcao
reduc
infarct
volum
compar
although
show
promis
neuroprotect
effect
specif
molecular
mechan
still
debat
origin
suggest
bind
nno
thu
prevent
nno
bind
howev
recent
studi
show
bind
pdz
domain
nno
inhibit
complex
thu
might
direct
inhibitor
complex
act
yet
unknown
mechan
addit
compound
tramipros
homotaurin
acid
piperidin
honokiol
propos
inhibit
ternari
complex
case
specif
mechan
remain
unclear
due
gener
low
affin
small
molecul
target
pdz
domain
viabl
approach
design
inhibitor
pdz
domain
seem
develop
inhibitori
peptid
peptidomimet
figur
sever
studi
identifi
key
amino
acid
requir
bind
attempt
design
modifi
short
peptid
fragment
increas
stabil
affin
one
exampl
hexam
cript
peptid
ykqtsv
use
templat
p
ser
p
gln
substitut
glu
ly
respect
facilit
intramolecular
lactam
cycliz
figur
cycliz
strategi
increas
affin
tenfold
improv
halflif
peptid
disrupt
interact
cell
analogu
cript
peptid
ykqtkv
use
templat
parallel
synthesi
differ
peptid
modifi
p
ly
variou
organ
acid
led
increas
affin
first
peptid
inhibitor
develop
target
interact
nno
minim
excitotox
result
ischem
stroke
fusion
peptid
nine
amino
acid
ctermin
residu
nmdar
subunit
klssiesdv
nuclear
transcript
activ
proteinderiv
cell
penetr
peptid
tat
figur
found
reduc
infarct
size
tmcao
rat
model
later
found
use
proteom
analysi
interact
differ
protein
nno
found
essenti
nmdarinduc
cytotox
clinic
phase
ii
studi
reduc
number
infarct
patient
risk
embol
stroke
undergo
endovascular
brain
aneurysm
repair
reduc
infarct
size
current
investig
global
phase
iii
clinic
trial
escap
reduc
global
disabl
subject
major
acut
ischem
stroke
well
second
trial
canada
patient
acut
cerebr
ischemia
proven
effect
stroke
treatment
approv
treatment
pave
way
novel
strategi
stroke
treatment
also
treatment
strategi
target
intracellular
ppi
gener
pdz
domain
protein
particular
follow
discoveri
sever
studi
approach
investig
optim
endogen
ctermin
peptid
aim
increas
affin
well
improv
stabil
select
structur
first
two
pdz
domain
show
bind
pocket
similar
exploit
develop
tandemspecif
dimer
ligand
bridg
two
decam
peptid
csgsawetdv
disulfid
bond
figur
improv
affin
rel
monomer
ligand
approach
develop
first
show
pentamer
peptid
ietav
display
wt
affin
toward
wwwadvancedsciencenewscom
wwwadvtherapcom
subsequ
show
crosslink
two
peptid
peg
linker
optim
length
figur
result
affin
nm
increas
rel
monomer
peptid
notabl
shown
crosslink
peg
linker
substanti
prolong
plasma
stabil
later
studi
show
could
permeat
bloodbrain
barrier
bbb
thu
modifi
peg
linker
develop
includ
central
amin
handl
tat
peptid
ygrkkrrqrrr
attach
addit
render
bbb
permeabl
wwwadvancedsciencenewscom
wwwadvtherapcom
tabl
affin
indic
select
peptid
inhibitor
pdzmediat
proteinprotein
interact
inhibitor
affin
indic
b
statu
refer
ic
pain
stroke
preclin
ic
pain
stroke
preclin
tramipros
stroke
preclin
nm
k
stroke
preclin
k
stroke
phase
iii
trial
ykqtsv
analog
k
na
develop
k
pain
stroke
develop
tetrahydroquinolin
analog
k
na
develop
gssgdpawdetnl
multimer
analog
k
na
develop
dishevel
k
cancer
preclin
dishevel
kwygwf
k
cancer
preclin
scribbl
rswfetwv
k
cancer
develop
syntenin
cancer
preclin
cal
cyclo
crrrrfwqc
trv
k
cystic
fibrosi
develop
capit
letter
indic
standard
onelett
amino
acid
abbrevi
peptid
inhibitor
except
indic
naphthylalanin
compound
name
shown
quot
b
therapeut
indic
na
avail
increas
affin
nm
affin
increas
compar
correspond
monomer
peptid
demonstr
protect
ischem
brain
damag
mous
pmcao
model
dose
nmol
g
given
iv
improv
neuromuscular
function
surprisingli
show
signific
effect
later
shown
dose
depend
show
effect
mice
nmol
g
subsequ
studi
explor
first
seri
trimer
ligand
develop
target
three
pdz
domain
second
increas
plasma
stabil
dimer
ligand
tat
sequenc
replac
variou
fatti
acid
substanti
increas
halflif
rat
rel
later
studi
relat
approach
use
develop
dimer
ligand
target
dimer
tatconjug
variant
ctermin
peptid
nmdar
subunit
figur
surprisingli
could
decoupl
without
disrupt
interact
neuron
incub
ligand
show
nmdar
mobil
less
synapt
locat
similar
approach
seri
dimer
peptid
deriv
tarp
develop
result
affin
increas
rel
monomer
peptid
increas
ic
valu
obtain
dimer
ligand
incorpor
tat
sequenc
taken
togeth
dimer
monomer
peptid
target
seem
attract
method
increas
target
affin
plasma
stabil
furthermor
appear
multimer
strategi
suitabl
target
tandem
pdz
domain
nontandem
pdz
domain
though
affin
benefit
target
tandem
seem
higher
phase
iii
clinic
trial
dimer
ligand
latestag
preclin
studi
excit
see
potenti
new
stroke
treatment
explor
drug
target
addit
serv
proofofconcept
target
intracellular
ppi
pdz
domain
interact
uniqu
protein
human
genom
protein
contain
ntermin
pdz
binamphiphysinrv
bar
domain
figur
c
origin
clone
protein
kinas
bind
protein
found
multipl
tissu
organ
abundantli
brain
endocrin
tissu
skelet
muscl
tissu
human
proteom
atla
highli
evolutionarili
conserv
invertebr
human
suggest
import
biolog
function
pdz
domain
interact
number
neurotransmitt
receptor
transport
enzym
figur
particular
interact
ampar
dopamin
transport
dat
receiv
particular
attent
bar
domain
domain
facilit
dimer
bar
domain
believ
promot
tetramer
oligomer
figur
b
pdz
domain
interact
lipid
protein
ly
posit
explain
promiscu
bind
differ
ctermin
ligand
class
though
favor
class
ii
ligand
figur
loop
pdz
domain
contain
cysproci
motif
propos
promot
pdzpdz
dimer
zinc
bind
lipid
bind
bar
domain
hand
character
sens
curvatur
membran
influenc
synapt
local
function
target
protein
demonstr
possess
multipl
function
cn
particularli
regul
function
ampar
specif
receptor
subunit
bind
pdz
domain
show
canon
hydrogen
bond
network
hydrophob
insert
p
side
chain
coordin
p
ly
structur
pdb
class
ii
ligand
cooh
bind
pdz
domain
show
canon
hydrogen
bond
network
class
ii
ligand
hydrophob
insert
p
p
furthermor
ligand
display
partial
coordin
p
ly
ctermin
carboxyl
acid
backbonesid
chain
interact
p
carbonyl
ly
e
exampl
class
mimick
smallmolecul
compound
pdb
coordin
ctermin
carboxyl
acid
p
amid
hydrogen
pdz
backbon
ile
gli
ile
loop
hydrophob
insert
p
cyclopropan
ring
interact
stabil
hydrogen
bond
p
carbonyl
gln
side
chain
f
protein
interact
network
show
select
protein
highest
confid
score
interact
show
high
interconnect
differ
protein
respect
group
made
use
string
databas
inform
analysi
visual
tool
g
structur
bind
affin
inhibitor
target
pdz
domain
respect
affin
avail
adv
involv
endocytosi
ampar
longterm
depress
ltd
regul
ampar
traffick
express
synapt
plastic
suggest
play
role
rang
neurolog
disord
particular
chronic
pain
also
epilepsi
stroke
parkinson
diseas
schizophrenia
tabl
support
inform
also
led
research
pursu
inhibitor
potenti
therapeut
modal
pdzcontain
protein
ctermin
peptid
interact
protein
use
start
point
figur
first
smallmolecul
inhibitor
pdz
domain
e
ethyl
acryloylcarbam
identifi
screen
small
molecul
figur
screen
identifi
coupl
differ
smallmolecul
inhibitor
low
affin
potent
analogu
seem
irrevers
inhibitor
thu
pursu
shown
bind
k
rang
endogen
peptid
inhibit
pdzcontain
protein
moreov
shown
inhibit
coimmunoprecipit
subunit
ampar
cultur
hippocamp
neuron
influenc
recycl
intern
notabl
also
shown
block
express
longterm
depress
longterm
potenti
hippocamp
cornu
ammoni
neuron
acut
slice
accord
inhibit
bidirect
function
synapt
plastic
subsequ
studi
sar
studi
perform
number
analogu
synthes
howev
lead
rel
modest
improv
affin
research
biogen
idec
similarli
pursu
smallmolecul
inhibitor
publish
differ
small
molecul
includ
share
common
chemic
scaffold
includ
carboxyl
acid
close
locat
amid
bond
coordin
bind
carboxyl
bind
loop
pdz
domain
figur
describ
identifi
structurebas
design
k
nm
block
full
length
also
select
toward
versu
grip
compound
employ
mechanist
studi
examin
amyloid
beta
produc
synapt
depress
enhanc
endocytosi
ampar
demonstr
block
effect
synapt
transmiss
anoth
relat
compound
display
ic
use
structur
studi
cocryst
xray
structur
demonstr
bind
carboxyl
bind
loop
pick
pdz
domain
figur
g
recent
studi
discoveri
relat
molecul
describ
detail
highthroughput
screen
compound
perform
identifi
scaffold
subsequ
use
sar
studi
identifi
potent
inhibitor
first
peptid
inhibitor
pdz
domain
target
interact
ampar
subunit
figur
peptid
could
effici
displac
interact
cell
found
inhibit
ltd
show
effect
ltd
furthermor
requir
pkc
function
block
ltd
hippocamp
neuron
later
studi
shown
could
reduc
reinstat
cocain
seek
decoupl
ampar
interact
intraaccumb
shell
administr
develop
carri
ntermin
myristyl
produc
order
increas
cell
permeabl
plasma
halflif
peptid
involv
chronic
pain
also
underlin
administr
show
signific
effect
thermal
hyperalgesia
mechan
allodynia
follow
cci
also
implic
traffick
dat
therebi
implic
maintain
dopamin
homeostasi
elucid
import
interact
dat
ctermin
residu
dat
contain
bind
site
extrem
ctermin
ca
calmodulindepend
protein
kinas
bind
site
upstream
bind
site
fuse
tat
cpp
motif
render
peptid
cell
permeabl
peptid
block
interact
dat
well
interact
dat
altogeth
reduc
amphetamineinduc
dopamin
efflux
striatum
local
administr
furthermor
peptid
significantli
reduc
amphetamineinduc
hyper
locomotor
activ
iv
inject
suggest
administr
pdz
inhibitor
reduc
datmedi
effect
amphetamin
multifacet
protein
involv
sever
essenti
pathway
synapt
plastic
neurotransmitt
homeostasi
inhibitor
success
investig
relat
sever
indic
nevertheless
promiscu
role
could
suggest
target
system
intervent
strategi
could
unforeseen
consequ
homeostat
interplay
ion
channel
neurotransmitt
transport
kinas
famili
protein
encod
shank
gene
mutat
therein
implic
sever
neurolog
disord
includ
asd
schizophrenia
intellectu
disabl
tabl
support
inform
shank
gene
encod
figur
bestcharacter
protein
variat
gene
found
sever
patient
suffer
divers
neurolog
disord
direct
associ
diseas
found
patient
rare
genet
disord
lead
phelanmcdermid
syndrom
partial
complet
delet
chromosom
encod
haploinsuffici
caus
late
motor
develop
highli
delay
speech
intellectu
disabl
decreas
express
lead
lower
signal
transduct
overexpress
found
lead
manic
behavior
epilepsi
mice
hyperkinet
disord
mice
potenti
human
patient
involv
mani
signal
pathway
cn
includ
transport
regul
regul
signal
synaps
assembl
synaps
structur
function
tabl
support
inform
shank
protein
describ
key
scaffold
protein
due
role
linker
receptor
scaffold
protein
cytoskeleton
scaffold
protein
shank
protein
translat
varieti
isoform
result
intragen
promot
altern
splice
exon
uniprot
furthermor
shank
gene
seem
regul
epigenet
factor
shank
protein
express
excitatori
synapt
region
crucial
proper
synapt
transmiss
function
canon
isoform
uniprot
mous
human
contain
six
ankyrin
repeat
src
homolog
domain
pdz
domain
prolin
rich
region
pro
steril
alpha
motif
sam
figur
although
differ
mutant
found
gene
least
three
shown
associ
psychiatr
diseas
none
posit
within
pdz
domain
variant
posit
linker
region
domain
pdz
domain
interfer
bind
ctermin
ligand
chang
overal
structur
tandem
furthermor
sever
ptm
site
predict
howev
none
pdz
domain
pdz
domain
shank
protein
member
class
pdz
domain
posit
helix
propos
bind
primarili
ctermin
ligand
motif
figur
c
pdz
domain
interact
directli
subunit
ampar
link
nmdar
interact
gk
domain
bind
nmdar
pdz
domain
previous
describ
recent
shown
interact
pdz
domain
highli
depend
ntermin
extens
pdz
domain
enhanc
peptid
affin
significantli
nm
figur
implic
neurolog
disord
promot
develop
inhibitor
toward
pdz
domain
set
compound
discov
screen
smallmolecul
librari
contain
tetrahydroquinolin
carboxyl
core
structur
figur
e
compound
shown
displac
hexapeptid
modest
affin
rang
interestingli
show
inhibitor
affin
highli
depend
oligomer
state
kinas
interact
exchang
factor
form
trimer
complex
increas
local
proxim
therebi
local
concentr
bind
region
thu
increas
affin
figur
inspir
design
synthesi
seri
monomer
dimer
trimer
peptid
target
pdz
domain
howev
peptid
multimer
exhibit
modest
affin
increas
figur
pdzcontain
protein
known
play
import
role
cancer
tumor
format
metastasi
especi
canon
interact
pdz
domain
signal
pathway
fact
pdz
domain
protein
suggest
associ
cancer
variou
form
especi
skin
uterin
stomach
lung
cancer
tabl
support
inform
mani
cancercaus
mutat
detect
pdz
domain
major
amino
acid
substitut
chang
arg
gli
differ
amino
acid
major
mutat
appear
pdz
domain
membraneassoci
guanyl
kinas
ww
pdzcontain
protein
inadlik
protein
patj
pdz
domaincontain
protein
multipl
pdz
domain
protein
mutat
mpdz
twice
common
protein
present
cellcel
junction
figur
recogn
play
role
cancer
dishevel
dvl
also
known
dishevel
homolog
dsh
first
discov
drosophila
melanogast
mutat
dishevel
gene
caus
improp
wing
bodi
hair
locat
later
identifi
three
dishevel
protein
make
dvl
protein
famili
sequenc
align
protein
famili
reveal
three
conserv
domain
arrang
includ
ntermin
dishevelledaxin
dix
domain
central
pdz
domain
follow
ctermin
dep
domain
recogn
bind
short
peptid
motif
dvl
protein
later
identifi
key
mediat
wnt
signal
pathway
thu
import
embryon
adult
develop
b
c
canon
insert
type
ligand
aceantrl
cooh
red
pdz
domain
canon
hydrogen
bind
network
hydrophob
insert
p
leu
p
thr
coordin
furthermor
interact
support
side
chain
interact
p
arg
asp
p
gln
glu
smallmolecul
inhibitor
target
pdz
domain
e
hydrogen
bind
network
red
bind
pdz
domain
mimick
backbon
hydrogen
bond
network
p
p
residu
canon
ligand
hydrophob
insert
cyclopenten
moieti
bind
stabil
interact
nitro
group
arg
f
bind
trimer
red
pdz
domain
show
steric
hindranc
reduc
expect
avid
effect
expect
close
proxim
g
monomer
dimer
trimer
peptid
analogu
mimick
bind
pdz
domain
h
structur
sapap
cooh
red
bind
extend
variant
pdz
domain
show
ligandinduc
pdzpdz
dimer
pdb
hydrogen
bind
network
coordin
p
p
red
pdz
domain
extens
account
immens
affin
enhanc
ligand
specif
j
primari
sequenc
gene
locat
chromosom
encod
kda
aa
protein
locat
chromosom
encod
kda
aa
kda
aa
respect
crossspeci
analysi
show
highli
conserv
studi
mice
singl
dvl
gene
homologu
knockout
shown
phenotyp
rang
defect
social
behavior
development
defect
includ
abnorm
heart
skelet
cochlear
morpholog
suggest
uniqu
role
three
singl
dvl
gene
howev
analysi
doubl
tripl
dvl
knockout
reveal
novel
sever
phenotyp
suggest
overlap
redund
function
dvl
key
mediat
wnt
signal
pathway
evolutionari
conserv
initi
signal
cascad
crucial
embryon
develop
mainten
adult
tissu
homeostasi
regul
cell
prolifer
differenti
migrat
genet
stabil
apoptosi
maintain
adult
stem
cell
pluripot
state
wnt
signal
commonli
divid
canon
independ
noncanon
pathway
canon
signal
pathway
wnt
ligand
secret
glycoprotein
bind
ntermin
extracellular
cysteinerich
domain
g
proteincoupl
receptor
gpcr
famili
frizzl
fz
signal
propag
dvl
direct
interact
intern
recognit
motif
ktxxxw
locat
ctermin
region
fz
dvl
pdz
domain
follow
polymer
dvl
mediat
dix
domain
dvl
polym
function
structur
scaffold
platform
facilit
dissemin
wnt
signal
lead
activ
tcell
factor
tcf
depend
transcript
development
gene
gene
associ
tumorigenesi
noncanon
wnt
signal
pathway
refer
group
signal
pathway
lead
transcript
two
beststudi
noncanon
signal
pathway
planar
cell
polar
pcp
wntcalcium
pathway
initi
wnt
bind
fz
follow
intracellular
interact
dvl
howev
downstream
interact
partner
dvl
effector
differ
two
signal
pathway
ultim
pcp
pathway
lead
rearrang
cytoskeleton
thu
polar
cell
wntcalcium
pathway
regul
intracellular
releas
calcium
endoplasm
reticulum
er
given
pleiotrop
natur
wnt
signal
cascad
surpris
regul
pathway
associ
varieti
diseas
state
includ
fibrosi
neurodegener
cancer
tabl
support
inform
specif
aberr
wnt
signal
report
tumor
patient
hepatocellular
carcinoma
hepatoblastoma
colorect
cancer
acut
myeloid
leukemia
aml
chronic
myeloid
leukemia
cml
multipl
myeloma
gastric
cancer
impact
wnt
signal
cancerogenesi
colorect
cancer
particularli
well
describ
tightli
connect
loss
protein
adenomat
polyposi
coli
apc
downstream
effector
dvl
regul
tumor
suppressor
gene
function
loss
apc
result
constitut
activ
wnt
signal
thu
promot
transcript
gene
encod
oncoprotein
last
decad
inhibit
wnt
signal
pathway
emerg
attract
intervent
point
treatment
cancer
sever
studi
identifi
inhibitor
target
variou
point
along
pathway
particular
sever
small
molecul
peptidebas
inhibitor
target
dvl
describ
figur
first
dvl
inhibitor
target
pdz
domain
identifi
receptorbas
virtual
screen
nation
cancer
institut
nci
smallmolecul
librari
figur
later
group
develop
potent
smallmolecul
inhibitor
k
combin
quantit
structureact
relationship
analysi
structur
studi
anoth
dvlpdz
inhibitor
design
base
scaffold
shown
block
interact
ctermin
fz
dvl
k
suppress
tumor
growth
vivo
next
seri
dvl
inhibitor
describ
aim
mimic
side
chain
interact
fourth
amino
acid
nativ
pdz
ligand
optim
inhibitor
show
ic
valu
smallmolecul
inhibitor
develop
combin
silico
screen
structur
analysi
bind
dvl
k
cell
permeabl
properti
inhibit
wnt
signal
pathway
nonsteroid
antiinflammatori
drug
nsaid
best
known
painreliev
properti
inhibit
cyclooxygenas
cox
enzym
evid
suggest
nsaid
also
affect
wnt
signal
pathway
one
exampl
sulindac
clinoril
figur
f
suppress
canon
wnt
pathway
breast
cancer
lung
cancer
colon
cancer
cell
line
bind
pdz
domain
dvl
affin
k
anoth
studi
effort
identifi
smallmolecul
inhibitor
target
dvl
pdz
domain
base
screen
commerci
avail
compound
librari
identifi
hit
sever
compound
contain
indol
ring
identifi
lead
compound
although
significantli
increas
nuclear
compound
show
sever
cytotox
cell
viabil
assay
pursu
thu
ic
shown
activ
compound
less
cytotox
effect
howev
later
shown
poor
metabol
stabil
develop
deriv
construct
contain
piperidyl
moieti
carboxyl
group
show
improv
affin
ic
stabil
oral
activ
dosedepend
regul
pathway
nmr
experi
reveal
bind
site
locat
canon
pdz
bind
pocket
includ
three
residu
recent
effort
develop
small
molecul
target
pdz
domain
dvl
initi
gener
pharmacophor
model
base
xray
crystal
structur
dvl
pdzdapper
peptid
complex
nmr
structur
dvl
pdzsulindac
figur
f
model
use
screen
approxim
million
virtual
compound
initi
hit
valid
surfac
plasmon
reson
spr
show
eight
compound
bind
dvl
pdz
four
best
hit
contain
phenoxyacet
acid
group
show
highest
affin
k
studi
follow
gener
two
new
pharmacophor
model
base
molecular
dynam
md
simul
idax
peptid
rktghqickfrkc
dvl
pdz
interact
three
known
xray
crystal
structur
synthet
peptid
bind
dvl
pdz
virtual
librari
compris
million
compound
figur
structur
pseudo
class
ii
inhibitori
peptid
cooh
red
bind
pdz
domain
segment
polar
protein
dishevel
homolog
pdb
b
hydrogen
bond
network
bind
pdz
domain
show
higher
extent
hydrogen
bond
backbon
canon
binder
end
p
amid
hydrogen
furthermor
interact
stabil
hydrogen
bond
p
p
carbonyl
arg
side
chain
interact
p
tyr
p
ly
asp
c
structur
noncanon
inhibitori
peptid
cooh
red
bind
pdz
domain
pdb
hydrogen
bond
network
bind
pdz
domain
show
upward
shift
insert
ligand
hydrophob
insert
p
trp
p
val
backbon
leu
gli
ile
loop
coordin
p
asp
side
chain
p
ser
side
chain
coordin
carbonyl
interact
strengthen
backbon
interact
amid
hydrogencarbonyl
gli
p
ile
carbonylamid
hydrogen
e
structur
smallmolecul
sulindac
red
bind
pdz
domain
pdb
f
interact
present
sulindac
bind
pdz
domain
hydrogen
bond
present
sulindac
carboxyl
acid
leu
gli
ile
loop
sulindac
sulfoxid
arg
fluorin
indol
ring
system
sulindac
insert
hydrophob
pocket
act
p
hydrophob
residu
canon
binder
g
peptid
peptidomimet
smallmolecul
inhibitor
target
pdz
domain
wwwadvancedsciencenewscom
wwwadvtherapcom
examin
virtual
hit
identifi
experiment
valid
fluoresc
polar
fp
assay
one
compound
confirm
pdz
domain
binder
k
bind
mode
valid
nmr
shown
involv
residu
locat
locat
sever
peptidebas
inhibitor
dvl
pdz
describ
includ
three
inhibitor
base
sequenc
nativ
dvl
pdz
interact
partner
one
inhibitor
deriv
phage
display
screen
figur
nativederiv
peptid
sequenc
base
ctermin
region
dapper
dpr
idax
peptid
inhibitor
primarili
develop
use
molecular
probe
wnt
signal
pathway
gener
pdz
interact
requir
last
three
four
amino
acid
ctermin
tail
ligand
howev
dvl
pdz
shown
interact
intern
motif
case
idax
interact
dvl
pdz
via
ktxxxi
motif
therefor
neg
regul
wnt
signal
pathway
idax
peptid
acrktghqickffrkcnh
bind
k
rang
nativ
pdzligand
interact
bind
mode
verifi
nmr
studi
also
confirm
peptid
locat
groov
ctermin
region
dpr
dvldepend
regul
normal
vertebr
develop
via
canon
wntsignal
pathway
shown
interact
dvl
specif
last
four
amino
acid
ctermin
tail
dpr
slklmttv
suggest
requir
interact
dprdvl
canon
interact
confirm
nmr
interact
dvl
pdzdpr
deriv
peptid
later
valid
determin
affin
k
figur
research
respons
develop
smallmolecul
dvl
inhibitor
also
design
peptidebas
inhibitor
start
use
tripeptid
templat
compris
vvv
report
structur
water
interact
pdz
dvl
vvv
valid
nmr
next
amino
acid
side
chain
posit
p
examin
improv
bind
proteinogen
amino
acid
p
posit
vxv
scaffold
x
amino
acid
except
pro
virtual
introduc
tripeptid
vwv
simul
highest
bind
energi
valid
nmr
fluoresc
bind
experi
k
vwv
pdz
determin
compar
vvv
later
transmembran
protein
compris
vwv
motif
ctermin
identifi
dvl
binder
shown
attenu
signal
pathway
phage
display
also
use
identifi
peptidebas
inhibitor
dvl
first
ctermin
phagedisplay
peptid
librari
compris
uniqu
member
use
identifi
ligand
ten
uniqu
peptid
found
shown
prefer
ligand
compris
ctermin
motif
hydrophob
residu
aromat
residu
figur
b
second
attempt
use
phage
display
librari
compris
intern
peptid
ligand
lack
free
ctermini
identifi
peptid
group
three
sequenc
famili
subfamili
contain
conserv
asp
like
substitut
free
carboxyl
ctermini
affin
bind
mode
three
peptid
wkdygwidgk
sgnevwidgp
eivlwsdip
bind
pdz
domain
character
xray
crystallographi
figur
fp
detail
studi
pdz
reveal
flexibl
bind
cleft
accommod
linear
peptid
motif
well
intern
ligand
lead
peptid
k
valid
conjug
cpp
tag
antennapedia
fluorophor
peptid
enabl
intracellular
locat
visual
cell
peptid
readili
intern
inhibit
canon
signal
dosedepend
manner
shown
least
ten
time
potent
compar
compound
scribbl
scrib
first
discov
drosophila
melanogast
tumor
suppressor
gene
delet
caus
aberr
prolifer
outgrowth
tissu
human
scribbl
aa
protein
compris
ntermin
leucinerich
repeat
lrr
region
follow
four
pdz
domain
flank
ctermin
tail
figur
protein
involv
establish
cell
polar
cell
migrat
tight
junction
dysregul
scribbl
shown
promot
cell
prolifer
tumorigenesi
mammalian
scribbl
part
intracellular
protein
complex
compris
disk
larg
lethal
giant
larva
protein
complex
locat
basolater
compart
epitheli
cell
requir
establish
apicalbas
cell
polar
growth
control
disrupt
apicalbas
polar
lead
uncontrol
cell
prolifer
thu
stimul
epithelialtomesenchym
transit
emt
major
factor
cancer
develop
addit
scribbl
shown
part
hippo
pathway
evolutionarili
conserv
kinas
signal
pathway
involv
organ
size
control
tissu
homeostasi
scribbl
interact
transmembran
receptor
upstream
regul
hippo
pathway
via
pdz
domain
howev
interact
mechan
conserv
across
speci
ctermin
amino
acid
sequenc
human
mous
zebrafish
constitut
class
pdz
bind
motif
htev
bind
motif
report
respons
interact
scribbl
drosophila
fatlik
protein
also
report
interact
scribbl
interact
howev
depend
ctermin
pdz
bind
motif
htev
suggest
scribbl
recogn
intern
epitop
drosophila
scribbl
also
interact
protein
exchang
factor
pix
guanin
nucleotid
exchang
factor
small
gtpase
figur
interact
cterminu
pawdetnl
four
pdz
domain
scribbl
studi
detail
xray
crystal
structur
peptid
bind
highlight
bind
prefer
specif
achiev
figur
interact
depend
side
chain
leu
thr
glu
trp
primari
determin
select
trp
trp
form
hydrophob
interact
wwwadvancedsciencenewscom
wwwadvtherapcom
figur
domain
organ
scribbl
uniprot
pdz
ligand
class
prefer
scribbl
ctermin
pdz
bind
motif
b
align
clustal
omega
scribbl
show
full
sequenc
conserv
c
structur
overlay
scribbl
pdb
grey
pdb
wheat
show
high
degre
structur
conserv
two
domain
structur
overlay
peptid
cooh
red
bind
blue
bind
scribbl
pdb
grey
show
highli
conserv
backbon
side
chain
organ
p
p
less
conserv
main
chain
side
chain
configur
p
p
bind
e
side
chain
interact
also
highli
conserv
interact
stabil
side
chain
interact
red
arc
p
p
p
ser
ser
respect
furthermor
interact
stabil
interact
blue
arc
p
trp
tyr
stabil
side
chain
interact
red
arc
p
p
p
p
ser
ser
ser
respect
furthermor
interact
stabil
c
interact
blue
arc
p
trp
pro
f
g
structur
class
ii
ligand
cooh
bind
tandem
scribbl
pdb
structur
show
secondari
bind
pocket
indic
dark
blue
dash
line
besid
canon
indic
light
blue
dash
line
p
phe
insert
hydrophob
patch
p
gln
coordin
two
ser
residu
respect
shown
adv
pack
wherea
trp
rotat
form
hydrogen
bond
interact
also
form
c
h
interact
sequenc
align
four
scribbl
protein
reveal
select
profil
attribut
sequenc
differ
rather
structur
differ
figur
c
prefer
select
valid
cellular
context
use
endogen
express
insight
tandem
show
bind
class
ligand
enhanc
secondari
bind
pocket
form
canon
bind
pocket
back
side
bind
pocket
figur
phage
display
use
gener
highaffin
peptid
inhibitor
target
scribbl
figur
one
promis
hit
rswfetwv
shown
bind
ic
valu
respect
import
amino
acid
side
chain
posit
confirm
ala
substitut
affin
peptid
verifi
spr
independ
studi
expect
previous
report
result
peptid
select
thu
bind
k
valu
respect
scribbl
promis
target
develop
anticanc
drug
howev
major
challeng
design
develop
pdz
select
inhibitor
far
achiev
syntenin
describ
character
novel
melanoma
differentiationassoci
gene
henc
name
melanoma
differentiationassoci
gene
sinc
sever
addit
name
includ
syndecan
bind
protein
scaffold
protein
cytoplasm
domaininteract
protein
employ
syntenin
shown
regul
transmembranereceptor
traffick
tumorcel
metastasi
exosom
product
neuronalsynaps
format
syntenin
gene
locat
chromosom
encod
kda
protein
aa
compris
aa
unstructur
ntermin
domain
ntd
follow
two
adjac
pdz
domain
short
aa
ctermin
domain
ctd
figur
sequenc
analysi
across
speci
shown
syntenin
highli
conserv
homologu
rat
mous
zebrafish
xenopu
loss
syntenin
function
mice
show
major
effect
mild
phenotyp
intestin
homeostasi
auditorycu
fear
memori
report
syntenin
highli
express
human
fetal
develop
rel
low
level
adult
tissu
number
independ
studi
indic
syntenin
overexpress
variou
cancer
includ
melanoma
glioblastoma
breast
cancer
urotheli
cell
cancer
scaffold
activ
syntenin
mainli
regul
two
pdz
domain
figur
b
sever
nmr
xray
crystal
structur
ligand
bound
syntenin
reveal
interact
select
domain
determin
combin
three
bind
pocket
bind
amino
acid
side
chain
differ
properti
figur
f
exampl
interact
via
p
p
figur
wherea
receptor
util
p
p
figur
structur
analysi
bound
variou
peptid
ligand
reveal
bind
site
induc
conform
chang
helix
thu
adopt
induc
fit
depend
specif
interact
partner
although
interact
partner
syntenin
show
prefer
frizzl
insulinlik
growth
receptor
describ
higher
affin
pdz
domain
syntenin
also
found
interact
membran
lipid
particular
phosphatidylinositol
pip
interact
interact
also
abl
recruit
ctermin
form
trident
complex
figur
present
cellular
compart
would
favor
specif
cellular
locat
syntenin
syntenin
uniqu
function
facilit
intracellular
extracellular
event
invas
thu
evolv
promis
target
cancer
intervent
first
smallmolecul
syntenin
inhibitor
figur
develop
fragmentbas
drug
design
nmr
screen
inhous
assembl
fragment
librari
compris
compound
syntenin
two
fragment
identifi
mainli
interact
domain
within
interfac
two
pdz
domain
combin
molecular
dock
sar
studi
guid
synthesi
dimer
compound
affin
determin
k
nmr
shown
inhibit
syntenin
bind
egfrviii
treatment
vivo
glioma
model
result
smaller
less
invas
tumor
enhanc
surviv
phage
display
use
identifi
intern
ctermin
peptid
inhibitor
syntenin
includ
potenti
ligand
bestcharacter
phage
display
hit
heptam
skkewyv
peptid
figur
sequenc
correspond
ctermin
protein
involv
cell
adhes
skkewyv
bind
fulllength
syntenin
k
interact
syntenin
valid
immunoblot
coloc
endogen
protein
first
pdz
bind
motif
viral
protein
discov
year
ago
gene
product
found
human
tlymphotrop
viru
type
human
papilloma
viru
hpv
human
adenoviru
ad
human
retroviru
infect
lymphocyt
transcript
factor
tax
crucial
element
malign
transform
infect
cell
contain
ctermin
pdz
bind
motif
interestingli
tax
protein
close
relat
nonleukemogen
lack
pdz
bind
motif
significantli
lower
transform
potenti
tax
human
adenoviru
type
region
gene
product
anoth
viral
protein
target
sever
pdzcontain
protein
ctermin
pdz
bind
motif
caus
eye
infect
human
mammalian
speci
viral
play
key
role
tumorigenesi
adv
therap
show
similar
insert
two
peptid
bind
pocket
c
electron
densiti
map
peptid
show
similar
electron
densiti
distribut
p
p
despit
low
sequenc
similar
especi
noncanon
interact
p
ly
glu
p
arg
glu
show
similar
electron
densiti
suggest
target
evolut
toward
mimick
endogen
pdz
ligand
graphic
model
pdzbodi
protein
bind
canon
bind
pocket
optim
ctermin
residu
obtain
addit
affin
specif
optim
pdz
domain
fuse
protein
glyser
linker
make
pdzbodi
pdzlxxll
chimera
human
papillomaviru
hpv
hijack
cell
infect
interact
endogen
protein
welldescrib
transcript
factor
tumor
suppressor
sever
pdzcontain
protein
bind
ubiquitin
ligas
hpv
target
pdz
domain
protein
degrad
figur
close
differ
type
hpv
document
small
portion
may
caus
cancer
socal
highrisk
hpv
hpv
protein
shown
interact
low
highrisk
hpv
highrisk
cancercaus
hpv
protein
contain
ctermin
pdz
bind
motif
recogn
differ
pdz
domain
protein
depend
hpv
strain
highrisk
hpv
protein
shown
associ
plethora
adv
pdz
domain
protein
includ
cell
polar
protein
tight
junction
protein
well
traffick
signal
protein
extens
review
see
ref
pdz
bind
motif
interact
pdz
domain
protein
also
report
sever
virus
hepat
b
viru
whose
core
protein
noncanon
ctermin
pdz
bind
motif
shown
interact
pdz
domain
pdz
domaincontain
protein
proteintyrosin
phosphatas
sever
acut
respiratori
syndromerel
coronaviru
pdz
bind
motif
found
viral
protein
e
play
key
role
viral
entri
releas
genom
replic
mutat
analysi
shown
presenc
least
one
function
pdz
bind
motif
either
e
necessari
viru
viabil
kaposi
sarcoma
herpesviru
express
pdzlim
domaincontain
protein
gene
repress
enabl
tumorigenesi
tumor
mainten
infect
cell
syntenin
recruit
plasma
membran
infect
cell
overexpress
syntenin
shown
reduc
infect
wide
varieti
pdz
domain
protein
found
interact
viral
protein
howev
pdz
domain
protein
seem
common
other
subset
cellular
pdz
domain
protein
target
otherwis
unrel
viral
protein
demonstr
import
understand
specif
bind
event
cellular
effect
quest
develop
new
antivir
drug
synapseassoci
protein
transcrib
gene
wide
express
human
vertebr
previous
describ
part
maguk
famili
figur
support
inform
play
key
role
regul
apicobas
polar
epitheli
cell
part
highli
conserv
scribbledlglgl
complex
scribbl
involv
regul
cell
polar
cell
shape
adhes
sever
signal
pathway
previous
describ
scribbl
shown
interact
tax
pdz
bind
motif
affect
function
subcellular
local
remov
cell
membran
overexpress
tax
also
shown
inhibit
abil
arrest
cell
cycl
progress
envelop
glycoprotein
env
also
shown
interact
viral
infect
env
contain
canon
ctermin
pdz
bind
motif
conserv
howev
mutant
viru
lack
motif
found
unabl
recruit
consequ
reduc
abil
transmit
infect
nonmut
htlv
occur
trigger
cellcel
contact
lymphocyt
act
tumor
suppressor
case
protein
suspect
exert
gainoffunct
upon
disrupt
function
tight
junction
reloc
plasma
membran
mediat
phosphatidylinositol
activ
activ
deregul
cytosol
signal
pathway
lead
cell
surviv
metabol
enhanc
viru
replic
hpv
bind
target
figur
c
scribbl
proteasom
degrad
ctermin
pdz
bind
motif
role
hpv
play
transform
infect
cell
cancer
cell
consid
potenti
drug
target
hpv
bind
pdz
domain
protein
two
differ
epitop
contain
class
pdz
bind
motif
recogn
lxxllmotif
helix
exploit
gener
doubleepitop
inhibitor
clone
express
optim
pdz
domain
link
motifcarri
helix
bind
protein
differ
site
measur
k
bival
binder
denot
pdzbodi
greatli
improv
compar
wildtyp
pdz
bind
affin
figur
similar
approach
employ
anoth
group
instead
model
pdz
part
doubleepitop
inhibitor
addit
wellstudi
interact
viral
protein
hpv
scribbl
also
associ
hepat
c
viru
infect
cell
express
shown
decreas
scribbl
coloc
hepat
c
core
protein
shown
coloc
gag
protein
restrict
infect
tight
junction
preval
entryway
sever
virus
integr
membran
protein
cytoplasm
protein
associ
tight
junction
mani
pdz
domain
besid
scribbl
hpv
protein
associ
tight
junction
pdz
domain
protein
figur
interact
hpv
type
protein
promot
reloc
polar
protein
wherea
maguk
protein
relat
multipdz
domain
protein
target
degrad
also
target
protein
reloc
pdz
domain
protein
cytoplasm
contribut
viral
transform
similarli
also
bind
anoth
maguk
famili
protein
sequest
cytoplasm
contrast
nontumorigen
ad
type
type
unabl
bind
homolog
play
import
role
tight
junction
associ
glycoprotein
though
pdz
bind
motif
found
protein
cell
expos
glycoprotein
show
misloc
tight
junction
follow
decreas
express
level
cystic
fibrosi
transmembran
conduct
regul
cftr
associ
ligand
cal
also
known
gopc
fig
pist
gene
gopc
place
chromosom
wide
express
sever
differ
tissu
ncbi
gene
inactiv
gopc
gene
shown
trigger
globozoospermia
mice
gene
variant
mutat
tabl
support
inform
gene
rearrang
gopc
gene
gene
found
patient
lung
adenocarcinoma
osimertinib
resist
seen
emerg
role
cal
traffick
sever
membran
protein
intracellular
compart
primarili
tran
golgi
network
tgn
endosom
lysosom
thu
reduc
receptor
surfac
express
promot
protein
degrad
figur
human
cal
found
interact
sever
differ
protein
includ
ion
channel
cftr
gpcr
includ
adrenerg
receptor
traffick
protein
syntaxin
particular
interact
cftr
cal
studi
due
role
cystic
fibrosi
cal
promot
degrad
cftr
lysozym
therebi
reduc
amount
cftr
express
surfac
figur
cal
express
aa
protein
uniprot
contain
unstructur
n
termin
region
coiledcoil
domain
pdz
domain
ctermin
unstructur
region
mani
way
similar
also
contain
unstructur
nand
ctermini
pdz
domain
multimer
domain
figur
three
differ
isoform
result
altern
splice
found
isoform
lack
residu
coiledcoil
domain
potenti
affect
homo
heteromultimer
isoform
truncat
posit
remain
c
termin
residu
substitut
chang
ctermin
pdz
bind
motif
tyrleuv
pdz
domain
cal
contain
conserv
ntermin
indic
class
ligand
prefer
stx
current
structur
deposit
pdb
show
regular
pdz
domain
topolog
primari
differ
loop
case
annot
partial
helic
structur
indic
less
flexibl
loop
compar
pdz
domain
pdb
interestingli
deposit
structur
aromat
residu
trp
phe
tyr
posit
p
stack
interact
featur
seem
act
nonmotif
specif
residu
figur
mutat
residu
profound
effect
affin
result
dramat
loss
affin
highlight
import
upstream
interact
engin
select
pdz
domain
inhibitor
known
pdz
domain
ligand
screen
peptid
use
invert
peptid
spot
array
five
differ
pdz
domain
select
sequenc
examin
peptid
sequenc
align
defin
consensu
stxl
peptid
bind
cal
subset
peptid
screen
use
posit
scan
p
p
differ
amino
acid
obtain
ctermin
core
peptid
p
p
optim
peptid
combin
ntermin
elong
librari
screen
p
p
posit
select
peptid
wptsii
result
approach
modest
affin
howev
optim
peptid
cal
lost
affin
four
test
pdz
domain
also
interact
cftr
result
increas
select
elong
peptid
ten
residu
result
final
peptid
affin
maintain
select
cal
figur
h
later
shown
competit
inhibitor
cftr
bind
cal
stabil
variant
surfac
express
therebi
increas
cftr
conduct
addit
work
show
substitut
p
arg
ly
coupl
fluorobenzen
side
chain
amin
increas
affin
twofold
figur
substitut
p
p
serileil
thrargval
trv
also
shown
yield
modest
increas
affin
figur
h
make
peptid
wqvtrv
cell
permeabl
plasma
stabl
p
val
substitut
cy
fuse
cpp
motif
crrrrf
upon
oxid
form
intramolecular
disulfid
bridg
p
cy
ntermin
cy
figur
peptid
found
bind
cal
k
nm
reduc
condit
bind
cal
nonreduc
condit
furthermor
shown
cycliz
increas
serum
halflif
cellular
uptak
compar
linear
noncpp
peptid
respect
base
core
motif
trv
calista
therapeut
develop
seri
inhibitor
combin
core
motif
tat
cpp
moieti
connect
differ
linker
compound
signific
addit
effect
cftr
conduct
administ
togeth
lumacaftor
acetyl
ntermin
insert
esteras
cleavabl
linker
ctermin
amid
acygrkkrrqrrrglycoylwqvtrvnh
figur
found
enhanc
effect
measur
channel
conduct
nevertheless
remain
unclear
ntermin
amid
still
allow
bind
pdz
domain
cal
recent
work
shown
pdz
domain
inhibitor
cal
also
noncompetit
inhibitor
work
alloster
modul
canon
ligand
bind
screen
smallmolecul
librari
consist
compound
identifi
three
compound
md
bound
pdz
domain
cal
affin
figur
primarili
perturb
residu
around
canon
bind
pocket
md
shown
perturb
area
adjac
bind
pocket
also
confirm
xray
crystal
structur
figur
cy
side
chain
coval
link
md
linkag
highli
depend
experiment
condit
case
compound
found
highli
cytotox
affect
cell
prolifer
induc
cell
apoptosi
anoth
studi
use
cysteinereact
compound
ed
figur
em
found
modul
bind
pdz
domain
cal
figur
although
ed
em
md
like
limit
therapeut
use
target
pdz
domain
alloster
inhibitor
reactiv
cy
residu
might
use
comparison
pdz
domain
sequenc
show
pdz
domain
contain
one
cy
sequenc
tabl
support
inform
exampl
regul
g
protein
signal
contain
four
cy
residu
pdz
domain
three
posit
bottom
canon
bind
pocket
potenti
act
bind
pocket
gate
mechan
pdb
discoveri
cal
key
influenc
cftr
channel
degrad
current
modul
bronchial
epitheli
cell
led
idea
target
cal
treatment
cystic
fibrosi
patient
identifi
variant
increas
surfac
lifetim
wwwadvancedsciencenewscom
wwwadvtherapcom
channel
restor
channel
conduct
howev
high
affin
select
inhibitor
cal
still
develop
modern
omic
studi
combin
interact
array
peptid
librari
key
resourc
mine
new
drug
target
human
diseas
one
first
clue
potenti
target
come
tissu
express
profil
express
chang
diseas
state
addit
potenti
target
must
valid
demonstr
direct
link
pharmacolog
intervent
modif
diseas
mechan
pdzcontain
protein
distribut
mainli
tissu
demand
cell
polar
exert
function
human
protein
atla
point
cerebr
cortex
smooth
muscl
tissu
highest
transcript
count
pdzcontain
protein
may
reflect
direct
requir
synapt
transmiss
muscl
contract
respect
figur
even
though
mani
ppi
muscl
mediat
pdz
domain
interact
potenti
pharmacolog
intervent
point
yet
suggest
brain
two
pdzcontain
protein
emerg
potenti
applic
alzheim
diseas
ad
interact
protein
mint
hightemperatur
requir
serin
proteas
final
epitheli
tissu
also
requir
strict
cellpolar
partitioningdefect
par
protein
complex
suggest
one
point
intervent
cancer
therapeut
mint
famili
intracellular
adaptor
protein
includ
brainspecif
ubiquit
express
mint
share
similar
domain
structur
compris
variabl
nterminu
conserv
cterminu
nterminu
contain
mi
region
follow
calciumcalmodulindepend
serin
proteas
interact
ci
region
contain
mi
region
neither
region
ctermin
region
conserv
among
mint
compris
phosphotyrosin
bind
ptb
domain
follow
linker
arm
two
tandem
pdz
domain
figur
relev
mint
ad
first
aros
coloc
mint
amyloid
deposit
postmortem
human
brain
slice
howev
effect
knockout
mice
model
ad
inconsist
result
either
increas
decreas
amyloid
beta
level
molecular
mechan
suggest
role
mint
ad
involv
traffick
amyloid
precursor
protein
app
secretas
complex
promot
ppi
mintapp
ptb
domain
mint
protein
interact
app
ctermin
region
peptid
motif
yenpti
first
pdz
domain
mint
interact
constitu
secretas
complex
potenti
peptid
inhibitor
mint
ptb
app
mint
pdz
presenilin
interact
could
reduc
level
prevent
recruit
app
secretas
complex
evid
mechan
come
reduct
level
mice
brain
genet
replac
app
gene
app
variant
lack
last
amino
acid
includ
yenpti
sequenc
addit
presenilin
app
addit
mint
interact
partner
report
also
believ
play
role
amyloidogen
pathway
anoth
protein
potenti
relev
treatment
ad
human
protein
belong
famili
proteas
compris
compos
regulatori
ntermin
region
follow
serineproteas
domain
ctermin
pdz
domain
figur
wide
express
human
tissu
enrich
skin
reproduct
tissu
brain
found
cytoplasm
extracellular
space
cortex
human
brain
express
pdzcontain
protein
almost
twice
transcriptcount
express
downregul
breast
brain
liver
cancer
describ
tumorsuppress
factor
promot
cell
death
relev
ad
suggest
first
due
coloc
human
brain
slide
use
immunohistochemistri
furthermor
incub
proteas
inhibitor
dosedepend
reduc
level
nontransfect
astrocyt
later
demonstr
could
degrad
aggreg
tau
protein
anoth
critic
featur
ad
patholog
tau
coloc
human
ad
brain
slice
role
pdz
domain
tau
recent
investig
bacteri
htra
pdz
domain
exert
alloster
control
proteolyt
activ
contrast
human
requir
pdz
domain
fibril
cleavag
disaggreg
tau
protein
howev
length
cleavag
product
influenc
presenc
pdz
domain
suggest
precis
function
substrat
process
still
unclear
discoveri
pdz
ligand
enhanc
proteolyt
activ
similarli
bacteri
htra
could
repres
critic
therapeut
intervent
ad
epitheli
cell
abil
defin
apic
basal
compart
essenti
requir
respond
effect
chang
intraand
extracellular
environ
one
major
protein
complex
cellular
polar
process
consist
atyp
protein
kinas
c
apkc
contain
pdz
domain
ctermin
flank
phox
domain
homooligomer
domain
contain
one
pdz
domain
three
figur
express
low
level
normal
human
tissu
upregul
describ
renal
carcinoma
gastric
cancer
essenti
deliveri
pkc
apic
epitheli
surfac
cterminu
bind
local
membran
pdz
domain
par
complex
play
pivot
role
control
cell
polar
unexpect
also
implic
human
carcinogenesi
exampl
knockdown
rnai
trigger
rapid
tumor
growth
metastat
colon
presenc
oncogen
target
cell
polar
signal
could
repres
novel
therapeut
intervent
block
cell
prolifer
prevent
epithelialtomesenchym
transit
emt
particular
protein
involv
pathway
cancer
cell
overexpress
ctermin
mutant
wwwadvancedsciencenewscom
wwwadvtherapcom
reduc
emt
nmumg
cell
also
number
incid
metastat
lung
tumor
modul
signal
could
repres
select
intervent
cancer
treatment
pdz
domaincontain
protein
play
plethora
import
role
cell
signal
particularli
mediat
signal
integr
membran
protein
intracellular
signal
partner
thu
mani
pdz
domain
protein
also
play
decis
role
diseas
henc
protein
relev
target
drug
discoveri
effort
howev
pdz
domain
also
rather
promiscu
protein
often
bind
sever
differ
partner
typic
ctermin
region
could
therefor
concern
achiev
select
toward
specif
pdz
domain
moreov
also
realiz
develop
druglik
smallmolecul
inhibitor
pdz
domain
far
straightforward
key
issu
like
elong
bind
pocket
ctermin
peptid
coordin
via
termin
carboxyl
group
also
network
backbon
hydrogen
bond
seem
difficult
mimic
small
molecul
accord
advanc
compound
target
pdz
domain
protein
peptid
peptid
previous
consid
attract
drug
candid
see
increas
number
peptid
clinic
develop
gener
peptid
even
higher
success
rate
small
molecul
outlin
review
sever
promis
pdz
domain
protein
target
therapeut
peptid
potenti
small
molecul
support
inform
avail
wiley
onlin
librari
author
